The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms
But acquisition charges drag earnings into loss
Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
The innovation is particularly suited for bone and cartilage repair
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Subscribe To Our Newsletter & Stay Updated
